Search Within

Madhu Mazumdar

Formats
  1. Journal Article (104)
  2. Meeting Abstract (21)
  3. Book Section (1)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (89)
  2. Solid Tumor Oncology Division (86)
  3. Genitourinary Oncology Service (70)
  4. Surgery (61)
  5. Survivorship Research (50)
  6. Radiology, Department of (31)

More Groups

People
  1. Robert Motzer (48)
  2. Dean Bajorin (41)
  3. George Bosl (30)
  4. Jennifer Bacik (26)
  5. Vaia Vlamis (20)
  6. Jose Guillem (17)

More People

Years
  1. 2013 (1)
  2. 2012 (1)
  3. 2011 (2)
  4. 2007 (2)
  5. 2006 (2)
  6. 2005 (9)

More Years

Publications
  1. Journal of Clinical Oncology (48)
  2. Annals of Surgical Oncology (8)
  3. Cancer (6)
  4. Investigational New Drugs (6)
  5. Statistics in Medicine (6)
  6. Annals of Surgery (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (48)
  2. Springer (17)
  3. American Association for Cancer Research (8)
  4. Elsevier Science, Inc. (8)
  5. Wiley Blackwell (8)
  6. Lippincott Williams & Wilkins (7)

More Publishers

Results (127)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients
    Journal Article

    Motzer, R. J.; Mazumdar, M.; Sheinfeld, J.; Bajorin, D. F.; Macapinlac, H. A.; Bains, M.; Reich, L.; Flombaum, C.; Mariani, T.; Tong, W. P.; more...
    Journal of Clinical Oncology (2000)

    Fulltext@MSK | Save
  • Phase I evaluation of sequential doxorubicin + gemcitabine then ifosfamide + paclitaxel + cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract
    Journal Article

    Dodd, P. M.; Mccaffrey, J. A.; Hilton, S.; Mazumdar, M.; Herr, H.; Kelly, W. K.; Icasiano, E.; Boyle, M. G.; Bajorin, D. F.
    Journal of Clinical Oncology (2000)

    Fulltext@MSK | Save
  • Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma
    Journal Article

    Dodd, P. M.; Mccaffrey, J. A.; Mazumdar, M.; Icasiano, E.; Higgins, G.; Herr, H.; Bajorin, D. F.
    Investigational New Drugs (2000)

    Fulltext@MSK | Save
  • Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography
    Journal Article

    Guillem, J. G.; Puig-la Calle, J. Jr; Akhurst, T.; Tickoo, S.; Ruo, L.; Minsky, B. D.; Gollub, M. J.; Klimstra, D. S.; Mazumdar, M.; Paty, P. B.; more...
    Diseases of the Colon and Rectum (2000)

    Fulltext@MSK | Save
  • Whole-body FDG-PET in patients with recurrent colorectal carcinoma. A comparative study with CT
    Journal Article

    Imbriaco, M.; Akhurst, T.; Hilton, S.; Yeung, H. W. D.; Macapinlac, H. A.; Mazumdar, M.; Pace, L.; Kemeny, N.; Erdi, Y.; Cohen, A.; more...
    Clinical Positron Imaging (2000)

    Fulltext@MSK | Save
  • Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer
    Journal Article

    Dodd, P. M.; Mccaffrey, J. A.; Mazumdar, M.; Scher, H.; Higgins, G.; Boyle, M. G.; Herr, H.; Bajorin, D. F.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: Final report of a phase II trial evaluating two dosing schedules
    Journal Article

    Bajorin, D. F.; Mccaffrey, J. A.; Dodd, P. M.; Hilton, S.; Mazumdar, M.; Kelly, W. K.; Herr, H.; Scher, H. I.; Icasiano, E.; Higgins, G.
    Cancer (2000)

    Fulltext@MSK | Save
  • Analysis of the insertion/deletion polymorphism of the human angiotensin converting enzyme (ACE) gene in patients with renal cancer
    Journal Article

    Usmani, B. A.; Janeczko, M.; Shen, R.; Mazumdar, M.; Papandreou, C. N.; Nanus, D. M.
    British Journal of Cancer (2000)

    Fulltext@MSK | Save
  • FDG-PET in esophageal cancer: Incremental value over CT
    Meeting Abstract

    Yeung, H. W.; Macapinlac, H. A.; Mazumdar, M.; Finn, R. D.; Larson, S. M.
    Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • Transitional cell carcinoma (TCC): Status of investigations with ifosfamide, paclitaxel, and cisplatin (ITP)
    Meeting Abstract

    Bajorin, D. F.; Dodd, P. M.; McCaffrey, J. A.; Hilton, S.; Mazumdar, M.; Donat, S.; Herr, H.; Icasiano, E.; Higgins, G.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save